Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. - Wikidata - awgldk - TriplyDB

Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.

Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.

http://www.wikidata.org/entity/Q34825072

about

Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review.Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database Upgrading and upstaging of low-risk prostate cancer among Korean patients: a multicenter study.The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades Predictive models for worsening prognosis in potential candidates for active surveillance of presumed low-risk prostate cancer.Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.Obesity and prostate cancer mortality.The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance Downgrading of biopsy based Gleason score in prostatectomy specimens.Predictive factors of Gleason score upgrading in localized and locally advanced prostate cancer diagnosed by prostate biopsy.The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database.Multiple cores of Gleason score 6 correlate with favourable findings at radical prostatectomy.pT3 Predictive Factors in Patients with a Gleason Score of 6 in Prostate Biopsies Are magnetic resonance imaging undetectable prostate tumours clinically significant? Results of histopathological analyses.Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database.A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients.Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6.Is small prostate volume a predictor of Gleason score upgrading after radical prostatectomy?Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.Prostate biopsy concordance in a large population-based sample: a Surveillance, Epidemiology and End Results study.Factors effective on survival after radical prostatectomy: To what extent is pre-operative biopsy Gleason scoring is confident in predicting the prognosis?Factors predicting Gleason score 6 upgrading after radical prostatectomy.Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.Predictive factors of unfavorable prostate cancer in patients who underwent prostatectomy but eligible for active surveillance.The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancer.Higher prostate weight is inversely associated with Gleason score upgrading in radical prostatectomy specimens.PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy.Active surveillance criteria for prostate cancer: can they be applied to Japanese patients?Concordance Between Prostate Needle Biopsy and Surgical Histopathology in a Primarily African-American Population.Utility of single cell genomics in diagnostic evaluation of prostate cancer.Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance.Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer.Global Gleason grade groups in prostate cancer: concordance of biopsy and radical prostatectomy grades and predictors of upgrade and downgrade.Is transperineal prostate biopsy more accurate than transrectal biopsy in determining final Gleason score and clinical risk category? A comparative analysis.MR imaging-guided prostate biopsy: technical features and preliminary results.

P2860

Q30234760-770DDC91-E94A-4D75-A5BB-A01218C98211 Q31121795-FA17CD54-A205-4004-B5BC-A232046F8187 Q33821885-D2959EB3-1147-4147-83DF-829CC375A7C0 Q34127059-A274049C-0649-4EC2-B6C9-A8FB08DC1424 Q36080355-F4633301-B132-47CB-B394-2855CFB17076 Q36090379-5BF0E2A9-68AD-4F63-A1B4-A4BA9AB87FC3 Q36254416-12293EF2-A501-440B-B87F-BE50B4B1A30F Q36318643-4DB55A57-F884-4436-8DFB-D7663982F501 Q36757440-C138D642-71BF-42C8-B58C-6AC060DD6DCC Q36935758-FD970DA4-5F70-43BB-929B-52D9FED0F54F Q36967312-DFAD2F9B-7933-4DC4-AC81-CE649A8B7249 Q37592409-CAB83CDB-FB6A-457A-AE66-0724D876C7E8 Q38176861-877AA8E0-101D-40BC-A331-FFA5D7E14E38 Q38480152-BABD8735-1AD7-4538-BC12-F38325ACFC06 Q38625047-4FC1E0DF-6087-49B1-B57E-3E7B15D4FE23 Q38640155-68187474-12DF-4A27-B790-7F13CDCE4164 Q38776763-B40F07CD-089A-4F4D-9DC6-0B09EBC86B21 Q39024065-452AC07B-C6E2-49BF-B02F-99AC8452B087 Q39211272-C87CBE98-570A-44A5-A63A-7BE03EF16571 Q39549640-CCBF5047-943E-4F58-A138-C2F0B757F761 Q39753928-B62B61D2-8EC9-4E6C-95A1-6A23A2931BA9 Q40100863-B1A1B918-AE61-48BE-B1DD-15D5BEBCB2AE Q41004893-019CBAFF-26FB-4395-A3A3-1F3D760F4D58 Q41214926-2F4EC63F-2985-443A-AD9F-0C40D65A28E7 Q41241036-8BD16921-75AD-4D2C-A239-24127F4E3C4E Q41851526-0846D82A-B047-44B1-9353-4A053827D257 Q41948735-7146015E-5DBB-4FDA-9D82-B16B80E42786 Q42139633-B6222C6A-38CE-4EBE-97D6-09282979560D Q42736742-08B5B88A-636E-409E-A1B5-D0C206AA8181 Q42781094-76607C22-3CFA-4101-9189-C8335CFB1ADB Q42878808-273766CF-8DCB-483F-B5D5-A092D2C20B40 Q43089446-5C3DE3CA-9E33-4E41-8101-2D5A0347AE17 Q43984442-93F0704B-9E13-465B-A9C0-B58A661ACC67 Q45771110-E2F7E4F0-619E-45D4-93D2-DEC87CE9872C Q46518241-AC4FFAAC-7AF2-4305-BB70-A234CDF5CA3E Q47149516-40DFE019-4C4D-4472-AE14-ADEE466FE283 Q47635662-950BF019-6A1C-4DDA-A8EA-E6B102D04DE1 Q48334271-92838379-89BC-4D82-A6F4-08EBC6983E33 Q50869484-9C3505D6-08D9-4B2D-969E-F4EAE895E76F Q53341367-1228E4E0-C33D-4BF6-9B0C-B549E8B24131

P2860

Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.

http://www.wikidata.org/entity/Q34825072

description

2007 nî lūn-bûn

@nan

2007 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մարտին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Upgrading and downgrading of p ...... ors and clinical implications.

@ast

Upgrading and downgrading of p ...... ors and clinical implications.

@en

Upgrading and downgrading of p ...... ors and clinical implications.

@nl

type

label

Upgrading and downgrading of p ...... ors and clinical implications.

@ast

Upgrading and downgrading of p ...... ors and clinical implications.

@en

Upgrading and downgrading of p ...... ors and clinical implications.

@nl

prefLabel

Upgrading and downgrading of p ...... ors and clinical implications.

@ast

Upgrading and downgrading of p ...... ors and clinical implications.

@en

Upgrading and downgrading of p ...... ors and clinical implications.

@nl

P1433

Q34825072-BED9E38E-4EBD-4969-B281-5A635CE8CF83

P1476

Q34825072-C1AEC5D7-E68A-4B07-86CB-35121DB106CE

P2093

Q34825072-2DBDCE4A-0EF8-4D47-B1BC-6D71710F4149

Q34825072-40BB8DF3-C69A-43C8-9514-CB28359AB268

Q34825072-5545D58D-C60D-4E34-8DCA-BDEC9523A451

Q34825072-5F2E2BA5-4CC7-4C1E-B3B1-7981724650BF

Q34825072-88596BBC-30E0-4810-B4D7-904640260923

Q34825072-C64FDE92-B3BF-48FE-A591-C15FFDBB4350

P2860

Q34825072-1F71252E-2B8D-45DB-92B9-581B239B569A

Q34825072-21323E89-7D65-422A-A45E-241E2CF8D72D

Q34825072-31E2E527-BCBB-45A6-8D24-4E6CFB101357

Q34825072-475781C6-D5BC-4822-8373-B04E86C30D86

Q34825072-4D1B093D-F277-482D-8083-5EC69949C9C4

Q34825072-62D50385-BF05-41E2-9AEA-8B10DE9552F0

Q34825072-7AECF541-D903-4BF4-A5F7-52CAB3E57FCE

Q34825072-823A6DF0-B90B-422A-8EE8-76E529EF61A4

Q34825072-86A7631A-EB49-4F6E-8C2D-140968A9D781

Q34825072-A2F418F7-A453-4DEA-9EC3-5CC41489B9DD

P304

Q34825072-FADAFB9E-10E4-478D-A7B1-43CF710AE665

P31

Q34825072-52F65CD8-FB1D-410B-9C95-341FCEEEA653

P356

Q34825072-73284049-D9EC-4710-830D-1E84CC40A77A

P407

Q34825072-27A502F4-B7EF-440F-B8D3-F9864D51B72C

P433

Q34825072-A307FDF0-5A0F-4B48-9B3A-68EC1DA257E4

P478

Q34825072-8D524898-03B1-42C9-B1DC-D8D3CEB62A69

P50

Q34825072-FD7E9530-88C1-4DBA-ADA9-3349F36670DB

P577

Q34825072-7BDA1751-ADD7-4F7D-8C70-C1956B0E2D7B

P5875

Q34825072-7D87BAAB-6879-4058-9F41-1C50EF36A56E

P698

Q34825072-CB769315-42D3-40B7-A580-30E963DACCA0

P932

Q34825072-C13BD787-55F2-42D0-B557-7AC9497C6A10

P356

J.UROLOGY.2006.10.036

P1433

P1476

Upgrading and downgrading of p ...... tors and clinical implications

@en

P2093

Christopher J Kane

http://www.w3.org/2001/XMLSchema#string

Christopher L Amling

http://www.w3.org/2001/XMLSchema#string

Joseph C Presti

http://www.w3.org/2001/XMLSchema#string

SEARCH Database Study Group

http://www.w3.org/2001/XMLSchema#string

Stephen J Freedland

http://www.w3.org/2001/XMLSchema#string

William J Aronson

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of sampling more cores on the predictive accuracy of pathological grade and tumour distribution in the prostate biopsy.

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.

Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer.

Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability.

The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial.

Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens.

Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.

Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings.

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.

Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

P304

495-499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UROLOGY.2006.10.036

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Martha K Terris

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6425546

http://www.w3.org/2001/XMLSchema#string

P698

17382152

http://www.w3.org/2001/XMLSchema#string

P932

3080253

http://www.w3.org/2001/XMLSchema#string